DETECTION OF HCV-SPECIFIC IFN-γ RESPONSES IN HCV ANTIBODY AND HCV RNA NEGATIVE INJECTING DRUG USERS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FLYNN JACQUELINE K; SACKS DAVIS RACHEL; HIGGS PETER; AITKEN CAMPBELL; MONEER SARAH; SUPPIAH VIJAY; TRACY LILLY; FFRENCH ROSEMARY; BOWDEN SCOTT; GEORGE JACOB; BHARADWAJ MANDVI; HELLARD MARGARET

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2014 | Volume:14 | Issue:1 Page(s): 1-14

Download Full-Text

View:

411

Download:

223

Cites:

Information Journal Paper

Title

DETECTION OF HCV-SPECIFIC IFN-γ RESPONSES IN HCV ANTIBODY AND HCV RNA NEGATIVE INJECTING DRUG USERS

Author(s)

Keywords

HEPATITIS C

DRUG USERS

COHORT STUDIES

Abstract

Background: Detectable HCV-specific cellular immune responses in HCV antibody and RNA negative people who inject drugs (PWID) raise the question of whether some are resistant to HCV infection. Immune responses from people who have been exposed to HEPATITIS C virus (HCV) and remain anti-HCV negative are of interest for HCV vaccine development, however, limited research addresses this area.Objectives: In a cohort of HCV antibody and RNA negative PWID, we assessed whether the presence of HCV-specific IFN-g responses or genetic associations provide any evidence of protection from HCV infection.Patients and Methods: One hundred and ninety-eight participants were examined longitudinally for clinical, behavioral, social, environmental and genetic characteristics (IFNL3 genotype [formally IL-28B] and HLA type). Sixty-one of the 198 participants were HCV antibody and RNA negative, with 53 able to be examined longitudinally for HCV-specific IFN-g ELISpot T cell responses.Results: Ten of the 53 HCV antibody and RNA negative participants had detectable HCV-specific IFN-g responses at baseline (18%). The magnitude of IFN-g responses averaged 131+/-96 SFC/106 PBMC and the breadth was mean 1+/-1 pool positive. The specificity of responses were mainly directed to E2, NS4b and NS5b. Participants with (10) and without (43) HCV-specific IFN-g responses did not differ in behavioral, clinical or genetic characteristics (P>0.05). There was a larger proportion sharing needles (with 70%, without 49%, P=0.320) and a higher incidence of HCV (with 35.1 per 100 py, 95% CI 14.6, 84.4, without 16.0 per 100 py, 95% CI 7.2, 35.6, P=0.212) in those with IFN-g responses, although not statistically significant. Half the participants with baseline IFN-g responses became HCV RNA positive (5.10), with one of these participants spontaneously clearing HCV. The spontaneous clearer had high magnitude and broad Th1 responses, favorable IFNL3 genotype and favorable HLA types.Conclusions: This study demonstrated the detection of HCV-specific IFN-γ responses in HCV antibody and RNA negative individuals, with a tendency for HCV-specific IFN-g responses to be associated with HCV exposure. The potential role of HCV-specific IFN-g responses in those who remained HCV RNA negative is of value for the development of novel HCV therapeutics.

Cites

THE PREVALENCE OF HEPATITIS C VIRUS INFECTION AND ITS RELATED RISK FACTORS AMONG THE RURAL POPULATION OF FARS PROVINCE, SOUTHERN IRAN

References

No record.

Cite

APA: Copy

FLYNN, JACQUELINE K, SACKS DAVIS, RACHEL, HIGGS, PETER, AITKEN, CAMPBELL, MONEER, SARAH, SUPPIAH, VIJAY, TRACY, LILLY, FFRENCH, ROSEMARY, BOWDEN, SCOTT, GEORGE, JACOB, BHARADWAJ, MANDVI, & HELLARD, MARGARET. (2014). DETECTION OF HCV-SPECIFIC IFN-γ RESPONSES IN HCV ANTIBODY AND HCV RNA NEGATIVE INJECTING DRUG USERS. HEPATITIS MONTHLY, 14(1), 1-14. SID. https://sid.ir/paper/306594/en

Vancouver: Copy

FLYNN JACQUELINE K, SACKS DAVIS RACHEL, HIGGS PETER, AITKEN CAMPBELL, MONEER SARAH, SUPPIAH VIJAY, TRACY LILLY, FFRENCH ROSEMARY, BOWDEN SCOTT, GEORGE JACOB, BHARADWAJ MANDVI, HELLARD MARGARET. DETECTION OF HCV-SPECIFIC IFN-γ RESPONSES IN HCV ANTIBODY AND HCV RNA NEGATIVE INJECTING DRUG USERS. HEPATITIS MONTHLY[Internet]. 2014;14(1):1-14. Available from: https://sid.ir/paper/306594/en

IEEE: Copy

JACQUELINE K FLYNN, RACHEL SACKS DAVIS, PETER HIGGS, CAMPBELL AITKEN, SARAH MONEER, VIJAY SUPPIAH, LILLY TRACY, ROSEMARY FFRENCH, SCOTT BOWDEN, JACOB GEORGE, MANDVI BHARADWAJ, and MARGARET HELLARD, “DETECTION OF HCV-SPECIFIC IFN-γ RESPONSES IN HCV ANTIBODY AND HCV RNA NEGATIVE INJECTING DRUG USERS,” HEPATITIS MONTHLY, vol. 14, no. 1, pp. 1–14, 2014, [Online]. Available: https://sid.ir/paper/306594/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops